COMMONWEALTH EQUITY SERVICES, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$8
+14.3%
12,702
-0.8%
0.00%
Q2 2023$7
-41.7%
12,802
-26.4%
0.00%
Q1 2023$12
-69.2%
17,405
-0.3%
0.00%
Q4 2022$39
-99.9%
17,455
-15.9%
0.00%
Q3 2022$66,000
-16.5%
20,754
-0.2%
0.00%
Q2 2022$79,000
-37.3%
20,804
-11.5%
0.00%
Q1 2022$126,000
-61.0%
23,504
-1.9%
0.00%
-100.0%
Q4 2021$323,000
-40.3%
23,953
-20.6%
0.00%0.0%
Q3 2021$541,000
+19.4%
30,176
+14.1%
0.00%0.0%
Q2 2021$453,000
-13.5%
26,455
+0.9%
0.00%0.0%
Q1 2021$524,000
+22.1%
26,222
+3.9%
0.00%0.0%
Q4 2020$429,000
+0.9%
25,247
-1.7%
0.00%0.0%
Q3 2020$425,000
-33.1%
25,676
-6.4%
0.00%
-50.0%
Q2 2020$635,000
+34.0%
27,436
+3.1%
0.00%0.0%
Q1 2020$474,000
-21.1%
26,602
-4.5%
0.00%0.0%
Q4 2019$601,000
+6.9%
27,857
-9.8%
0.00%0.0%
Q3 2019$562,000
-41.1%
30,887
+15.2%
0.00%
-50.0%
Q2 2019$954,000
+18.1%
26,813
+11.4%
0.00%0.0%
Q1 2019$808,000
+35.3%
24,075
+32.4%
0.00%
+33.3%
Q4 2018$597,000
-39.9%
18,183
+11.4%
0.00%
-40.0%
Q3 2018$994,000
+51.3%
16,320
+21.3%
0.01%
+66.7%
Q2 2018$657,000
-31.3%
13,457
+49.5%
0.00%
-40.0%
Q1 2018$956,000
+194.2%
9,004
+65.5%
0.01%
+150.0%
Q4 2017$325,0005,4400.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders